Searched for
DELHIVERY UPPER CIRCUIT
Glenmark Pharma hits 10% upper circuit, scales fresh 52-week high on $700 mn cancer drug dealGlenmark Pharma Share Price: Glenmark Pharmaceuticals' shares soared after its subsidiary, Ichnos Glenmark Innovation, inked a global licen...- ET Startup Awards’ greatest hits: a decade of spotting winnersPrevious winners of the ET Startup Awards (ETSA) have stood out amid a crowded ecosystem and have gone on to become successful businesses. ...
- New age firms' 29% Q1 revenue growth beats BSE 500, 1-yr stock returns better tooNew age companies showed strong performance in the April-June quarter, with an average 29% YoY revenue growth, led by Zomato. Paytm was an ...
- New unicorn alert; logistics cos ride q-comm bandwagonHappy Tuesday! Electric two-wheeler maker Ather is the newest unicorn in town. Details on this and more in today’s ETtech Morning Dispatch.
- Shadowfax’s Rs 3,000-crore IPO; Ola Electric shares rallyJoining its new-age peers, ecommerce logistics company Shadowfax is planning to go public. Details on this and more in today’s ETtech Top 5.
- Top startup and tech stories of the weekWelcome to a new edition of ETtech Unwrapped – our weekend newsletter packed with the most important stories from this week. Let’s take a q...
- Ola Electric listing pop; Honasa Consumer Q1 financialsOla Electric shares listed at flat price but later surged to hit the upper circuit. This and more in today’s ETtech Top 5.
- Ixigo IPO pops; AI jobs command premium payIxigo lists at about 50% premium, ends day at 20% upper circuit. This and more in today’s ETtech Top 5.
- Delhivery shares locked in 10% upper circuit on low-level buying“A meeting of the board of directors of the company will be held on November 11, 2022, inter alia to consider and approve the unaudited fin...
- Sensex rebounds 613 points; Nifty ends near 16K level; Bajaj twins rally 5%The 30 share pack Sensex rose 616.62 points or 1.16 per cent to close at 53,750.97. Its broader peer, Nifty50, added 178.95 points or 1.13 ...
Load More
